View in EDS HTML Full Text PDF Full Text

Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic Target.

Saved in:
Bibliographic Details
Title: Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic Target.
Authors: Holtzman NG; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, United States.; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Lebowitz MS; Sensei Biotherapeutics Inc., Gaithersburg, MD, United States., Koka R; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, United States., Baer MR; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, United States.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States., Malhotra K; Sensei Biotherapeutics Inc., Gaithersburg, MD, United States., Shahlaee A; Sensei Biotherapeutics Inc., Gaithersburg, MD, United States., Ghanbari HA; Sensei Biotherapeutics Inc., Gaithersburg, MD, United States., Bentzen SM; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, United States.; Department of Epidemiology and Biostatistics, University of Maryland School of Medicine, Baltimore, MD, United States., Emadi A; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, United States.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States.; Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD, United States.
Source: Frontiers in oncology [Front Oncol] 2021 Dec 22; Vol. 11, pp. 783744. Date of Electronic Publication: 2021 Dec 22 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35004304
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic Target.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Holtzman+NG%22">Holtzman NG</searchLink>; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, United States.; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Lebowitz+MS%22">Lebowitz MS</searchLink>; Sensei Biotherapeutics Inc., Gaithersburg, MD, United States.<br /><searchLink fieldCode="AU" term="%22Koka+R%22">Koka R</searchLink>; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, United States.<br /><searchLink fieldCode="AU" term="%22Baer+MR%22">Baer MR</searchLink>; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, United States.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States.<br /><searchLink fieldCode="AU" term="%22Malhotra+K%22">Malhotra K</searchLink>; Sensei Biotherapeutics Inc., Gaithersburg, MD, United States.<br /><searchLink fieldCode="AU" term="%22Shahlaee+A%22">Shahlaee A</searchLink>; Sensei Biotherapeutics Inc., Gaithersburg, MD, United States.<br /><searchLink fieldCode="AU" term="%22Ghanbari+HA%22">Ghanbari HA</searchLink>; Sensei Biotherapeutics Inc., Gaithersburg, MD, United States.<br /><searchLink fieldCode="AU" term="%22Bentzen+SM%22">Bentzen SM</searchLink>; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, United States.; Department of Epidemiology and Biostatistics, University of Maryland School of Medicine, Baltimore, MD, United States.<br /><searchLink fieldCode="AU" term="%22Emadi+A%22">Emadi A</searchLink>; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, United States.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States.; Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2021 Dec 22; Vol. 11, pp. 783744. <i>Date of Electronic Publication: </i>2021 Dec 22 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35004304
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2021.783744
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 783744
    Titles:
      – TitleFull: Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic Target.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Holtzman NG
      – PersonEntity:
          Name:
            NameFull: Lebowitz MS
      – PersonEntity:
          Name:
            NameFull: Koka R
      – PersonEntity:
          Name:
            NameFull: Baer MR
      – PersonEntity:
          Name:
            NameFull: Malhotra K
      – PersonEntity:
          Name:
            NameFull: Shahlaee A
      – PersonEntity:
          Name:
            NameFull: Ghanbari HA
      – PersonEntity:
          Name:
            NameFull: Bentzen SM
      – PersonEntity:
          Name:
            NameFull: Emadi A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 12
              Text: 2021 Dec 22
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 11
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1